Wetenschappelijke publicaties van Erasme

Wetenschappelijke publicaties van Erasme

  • Correction: Devices and techniques for bariatric and metabolic endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review.

  • Auteurs Boškoski I, Matteo MV, Shamah S, Abu Dayyeh BK, Bove V, De Siena M, Huberty V, Maselli R, Perretta S, Pontecorvi V, Stier C, Sharaiha RZ, Facciorusso A, Fuccio L
  • Revue Endoscopy
  • Date de publication 2025-11
Correction: Devices and techniques for bariatric and metabolic endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review.
  • Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.

  • Auteurs Innocenti T, Hanžel J, Truyens M, Lukaš M, Gordon H, Cremer A, Molnár T, Julsgaard M, Onali S, Todeschini A, Nardone OM, Noor NM, Caprioli F, Scaldaferri F, Argyriou K, Savarino EV, Brinar M, Hedin CRH, Vela González M, Armuzzi A, Blesl A, Aratari A, Quadarella A, Parigi TL, Bertani L, Ferracane C, Uzzan M, Michalopoulos G, De Bernardi A, Katsanos K, Balestrieri P, Piñero G, Karmiris K, Casbas AG, Nikolic S, Felice C, Pugliese D, Pastras P, Mocci G, Pouillon L, Mantzaris GJ, Ramos L, Casanova MJ, Koutroubakis IE, García MJ, Lobaton T, Dragoni G
  • Revue J Crohns Colitis
  • Date de publication 2025-11
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
  • The \"A-B-C\" classification reveals outcome trajectories in patients with hepatocellular carcinoma under atezolizumab/bevacizumab.

  • Auteurs Campani C, Galvanin C, Shim JH, Bouattour M, Touchefeu Y, Delhoume V, Rosmorduc O, Pascale A, An J, Lee HC, Regnault H, Thabut D, Paradis V, Calderaro J, Ziol M, Beaufrère A, Sayadi A, Amaddeo G, Allaire M, Olivier-Hourmand I, Metivier C, Rondini E, Ronot M, Ntandja-Wandji L, Ozenne V, Sidali S, Marra F, Hollande C, Ganne-Carrié N, Nahon P, Lequoy M, Sharma R, Ningarahi M, Trépo E, Nault JC
  • Revue Clin Gastroenterol Hepatol
  • Date de publication 2025-11
The \"A-B-C\" classification reveals outcome trajectories in patients with hepatocellular carcinoma under atezolizumab/bevacizumab.
  • Fluid Responsiveness.

  • Auteurs Calabrese A, Annoni F, Taccone FS
  • Revue Eur Heart J Acute Cardiovasc Care
  • Date de publication 2025-11
Fluid Responsiveness.
  • Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.

  • Auteurs Garg A, Strunk A, Midgette B, Frasier K, Cohn E, Aarts P, Alavi A, Alhusayen R, Bechara BFG, Bettoli V, Brassard A, Brown DP, Chandran NS, Choon SE, Cohen SR, Daveluy S, Del Marmol V, Dellavalle RP, Emtestam L, Farida B, Fernandez-Penas P, Flowers RH, Frew JW, Gebauer KA, Giamarellos-Bourboulis EJ, Goldfarb N, Horváth B, Hsiao JL, Jemec G, Lowes MA, Marzano AV, Matusiak L, Micheletti RG, Oon HH, Orenstein LAV, Ortega-Loayza AG, Paek SY, Pascual JC, Piguet V, Resnik BI, Rosmarin D, Roth GM, Sayed CJ, Silva DLF, Thorlacius L, Tzellos T, van der Zee H, van Straalen K, Ingram JR
  • Revue JAMA Dermatol
  • Date de publication 2025-11
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Decorative image of doctor and patient

Alle wetenschappelijke publicaties van het H.U.B.

Bekijk alle wetenschappelijke publicaties van het H.U.B.